Clinical trial
A Randomized, Sham-controlled Clinical Trial for Evaluation of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW II)
NCT05686317 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Sham-controlled Clinical Trial for Evaluation of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW II)
- Lead sponsor
- Edwards Lifesciences
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 1, 2023
- Completion date
- August 31, 2030
- Enrollment
- 100 (estimated)
- Sites
- 25
Conditions
As the registry lists them; a condition with its own page is linked.